95 related articles for article (PubMed ID: 11502883)
1. Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus.
Bijsterbosch MK; Ying C; de Vrueh RL; de Clercq E; Biessen EA; Neyts J; van Berkel TJ
Mol Pharmacol; 2001 Sep; 60(3):521-7. PubMed ID: 11502883
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
de Vrueh RL; Rump ET; van De Bilt E; van Veghel R; Balzarini J; Biessen EA; van Berkel TJ; Bijsterbosch MK
Antimicrob Agents Chemother; 2000 Mar; 44(3):477-83. PubMed ID: 10681306
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier.
de Vrueh RL; Rump ET; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
Pharm Res; 1999 Aug; 16(8):1179-85. PubMed ID: 10468017
[TBL] [Abstract][Full Text] [Related]
4. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis.
Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E
Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
6. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
Cerny J; Foster SA; Cheng YC
Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
[TBL] [Abstract][Full Text] [Related]
7. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
[TBL] [Abstract][Full Text] [Related]
8. Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1998 Nov; 54(5):907-17. PubMed ID: 9804626
[TBL] [Abstract][Full Text] [Related]
9. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic study on the cytostatic and tumor cell differentiation-inducing properties of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, adefovir)-collected publications.
Hatse S
Verh K Acad Geneeskd Belg; 2000; 62(5):373-84. PubMed ID: 11144686
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of 9-(2-phosphonylmethoxyethyl)adenine ester analogues, a series of anti-HBV structures with improved plasma stability and liver release.
Liao S; Fan SY; Liu Q; Li CK; Chen J; Li JL; Zhang ZW; Zhang ZQ; Zhong BH; Xie JW
Arch Pharm Res; 2014 Nov; 37(11):1416-25. PubMed ID: 24338503
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia.
Dallas S; Schlichter L; Bendayan R
J Pharmacol Exp Ther; 2004 Jun; 309(3):1221-9. PubMed ID: 14762102
[TBL] [Abstract][Full Text] [Related]
16. 9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase.
Hatse S; Schols D; De Clercq E; Balzarini J
Cell Growth Differ; 1999 Jun; 10(6):435-46. PubMed ID: 10392905
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles.
Bijsterbosch MK; van de Bilt H; van Berkel TJ
Biochem Pharmacol; 1996 Jul; 52(1):113-21. PubMed ID: 8678894
[TBL] [Abstract][Full Text] [Related]
18. Liver-targeted drug delivery using HepDirect prodrugs.
Erion MD; van Poelje PD; Mackenna DA; Colby TJ; Montag AC; Fujitaki JM; Linemeyer DL; Bullough DA
J Pharmacol Exp Ther; 2005 Feb; 312(2):554-60. PubMed ID: 15340017
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
Naesens L; Balzarini J; Bischofberger N; De Clercq E
Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]